Evidence map›Paper›PMID 38024289›Full record

ArticleIntegrative medicine research2023

Saruul Erdenebileg, Yang-Ju Son, Myungsuk Kim, Sarangerel Oidovsambuu, Kwang Hyun Cha, Jaeyoung Kwon, Da Seul Jung, Chu Won Nho

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Integrative medicine research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Antioxidants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Saruul ErdenebilegSmart Farm Research Center, Korea Institute of Science and Technology (KIST), Gangneung, South Korea.
Yang-Ju SonDepartment of Food and Nutrition, Chung-Ang University, Anseong, South Korea.
Myungsuk KimNatural Product Research Center, Korea Institute of Science and Technology (KIST), Gangneung, South Korea.
Sarangerel OidovsambuuNatural Product Chemistry Laboratory, Institute of Chemistry and Chemical Technology, Mongolian Academy of Sciences, Ulaanbaatar, Mongolia.
Kwang Hyun ChaNatural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung, South Korea.
Jaeyoung KwonNatural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung, South Korea.
Da Seul JungSmart Farm Research Center, Korea Institute of Science and Technology (KIST), Gangneung, South Korea.
Chu Won NhoSmart Farm Research Center, Korea Institute of Science and Technology (KIST), Gangneung, South Korea.
Korea Institute of Science and Technology · KRBio-Medical Science (South Korea) · KRChung-Ang University · KRMongolian Academy of Sciences · MN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The root of Methods: To investigate the anti-inflammatory effects and alleviation of IBD, using a methanol extract of Results: MESD significantly decreased nitric oxide (NO) and inflammatory cytokine levels in lipopolysaccharide (LPS)-induced RAW 264.7 cells Conclusion: Overall, MESD may be a potential natural product for the treatment of IBD by lowering inflammatory cytokine levels and altering gut microbiota composition.

Indexed as

DSS-induced colitisGut microbiotaInflammatory bowel diseaseInflammatory responseSaposhnikovia divaricata

Identifiers

PMID38024289
PMCPMC10630121
OpenAlexW4387766191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.